Interleukin 6 and Tumor Necrosis Factor Alpha As Biomarkers of Jnk Inhibition

Biomarkers for JNK inhibition are described that can be used for monitoring effectiveness of JNK inhibitors and monitoring treatment with JNK inhibitors.

Attached files:
WO 2010065850.jpg

Patents:
WO 2,010,065,850

Inventor(s): DAVIS ROGER J [US]; BUZO GUADALUPE SABIO [ES]; DAS MADHUMITA [US]

Type of Offer: Sale



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent